MALRX Mutual Fund

NAV$27.50

Fund Essentials - as of Mar 31, 2026

Net Assets
$1.7B
Expense Ratio
0.48%
Dividend Yield (Current)
7.61%
Holdings
90
Inception Date
Dec 22, 1999
Fund Family
BlackRock, Inc. (US)
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Semi-Annually

Performance

YTD+12.84%
1 Year+28.90%
3 Year+22.91%
5 Year+13.71%
10 Year+18.86%

Asset Allocation

Stocks: 98.97%
Cash: 0.11%
Other: 0.92%

Price Chart (6M)

Loading chart data...

Top Holdings

View All →
TickerNameWeight
NVDANvidia Corp7.21%
AAPLApple Inc6.63%
MSFTMicrosoft Corp 4.100 Feb 06 374.92%
AMZNAmazon.Com Inc4.30%
GOOGL'alphabet Inc., Class 'a''3.03%
Top 10 Concentration: 37.39%Report Date: Mar 31, 2026
Download all 90 holdings for MALRX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
7.61%
Frequency
Semi-Annually
Latest Distribution
$4.19
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how MALRX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$49$29/mo
Claim the $29 launch price
First 500 subscribers, then $49/mo. Cancel anytime. From MarketXLS, trusted since 2014.

MALRX Mutual Fund Overview

MALRX Mutual Fund (BlackRock Advantage Large Cap Core Fund Institutional Class) is managed by BlackRock, Inc. (US) with $1.70B in net assets. MALRX expense ratio is 0.48%, holding 90 positions across sectors including Information Technology, Industrials, Consumer Discretionary. Inception date: 1999-12-22.

MALRX performance shows a YTD return of 12.84%. The 1-year return is 28.90% and the 5-year return is 13.71%. MALRX dividend yield stands at 7.61%, paid semi-annually.

MALRX top holdings include Nvidia Corp (7.2%), Apple Inc (6.6%), Microsoft Corp 4.100 Feb 06 37 (4.9%), Amazon.Com Inc (4.3%), 'alphabet Inc., Class 'a'' (3.0%). View all MALRX holdings, sector breakdown, or dividend history.

MALRX can be compared against other funds using the overlap calculator or side-by-side comparison tool. MALRX alternatives are available via the screener, along with tax-loss harvesting opportunities.